Wellington Management is one of the world's largest independent asset managers, founded in 1928 and headquartered in Boston. Its Private Investing platform invests across sectors including enterprise software, fintech, consumer, healthcare, biotechnology, and climate technology, from early-stage venture through late-stage growth. The latest late-stage private fund (Wellington Hadley Harbor IV) closed at $2.6 billion.
Average disclosed round size is $184.3M (across 318 rounds with reported amounts).
Portfolio
277
Fund Size
$2.6B
Top Stage
Series C
Last 12 Mo
19
Team
Cara Hubbard
Investment Director
Drew Morales
Associate Director, Private Investments Value Creation
Erin Schmitz, CFA
Director, Private Investments
Jason Horowitz
Director of Alternatives, Americas
Sonali Wilson
Investment Director, Private Investment Capital Formation
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Tonsser | Series A | — | Sep 2026 |
 Muon Space | Series C | $250M | Aug 2026 |
 Crystalys Therapeutics Inc | Series B | $130M | Jul 2026 |
 Fore Biotherapeutics | Unknown | $67.4M | Jul 2026 |
 Higharc | Series C | $95M | Jun 2026 |
 RQ Biotechnology | Series A | $115M | Jun 2026 |
 Baseten | Series B | $1.5B | Jun 2026 |
 Nuclidium | Unknown | — | May 2026 |
 Quince | Series E | — | Mar 2026 |
 Encord | Series C | $60M | Feb 2026 |
| Nnyra health | Series A | — | Feb 2026 |
 Jelou | Series A | $10M | Jan 2026 |
 Caldera Therapeutics | Series A | $75M | Jan 2026 |
| RQ Biotechnology | Series A | $115M | Jan 2026 |
| AAngitia Bio | Series D | $130M | Jan 2026 |
 Artiva Biotherapeutics | Series B | $120M | Jan 2026 |
| Quince | Series E | $500M | Jan 2026 |
 Avere Therapeutics | Unknown | $320M | Jan 2026 |
| FForerunner | Series B | $26.3M | Jan 2026 |
 Metsera | Series B | $215M | Jan 2026 |
| EEleven Labs | Series D | — | Jan 2026 |
 Quantum-Systems | Series D | — | Jan 2026 |
| Baseten | Series E | $300M | Jan 2026 |
 Angitia Biopharmaceuticals | Series D | $130M | Jan 2026 |
 Crisp | Series B | $26M | Dec 2025 |
Top Co-Investors
Last updated: 27 September 2026